Tue, October 12, 2010
Mon, October 11, 2010
[ Mon, Oct 11th 2010 ]: Market Wire
SNY,GENZ,LH,AVB,MU
[ Mon, Oct 11th 2010 ]: Market Wire
ARAY,SI,VAR,TOMO,JMBA
Sun, October 10, 2010
Sat, October 9, 2010
Fri, October 8, 2010
Thu, October 7, 2010
[ Thu, Oct 07th 2010 ]: Market Wire
30pm CST
Wed, October 6, 2010
Tue, October 5, 2010
Mon, October 4, 2010
Sun, October 3, 2010
Fri, October 1, 2010
Thu, September 30, 2010
Wed, September 29, 2010
Tue, September 28, 2010
Mon, September 27, 2010
Sun, September 26, 2010
Sat, September 25, 2010
Fri, September 24, 2010
Thu, September 23, 2010
Wed, September 22, 2010
Tue, September 21, 2010
Mon, September 20, 2010

Affymax to Present at BIO Investor Forum

  Copy link into your clipboard //health-fitness.news-articles.net/content/2010/ .. 29/affymax-to-present-at-bio-investor-forum.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

PALO ALTO, Calif.--([ BUSINESS WIRE ])--Affymax, Inc. (Nasdaq: AFFY) today announced that Arlene Morris, the company's chief executive officer, will present at the 9th Annual BIO Investor Forum on Tuesday, October 5 at 2:30 p.m. PT (5:30 p.m. ET).

A live webcast of the presentation will be available on the investors section of the Company's website at [ www.affymax.com ]. A replay will also be available for 30 days following the presentation.

About Affymax, Inc.

Affymax, Inc. is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. Affymax's product candidate, Hematide(TM)/peginesatide, recently completed Phase 3 clinical trials for the treatment of anemia associated with chronic renal failure. For additional information, please visit [ www.affymax.com ].